Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma
Greta Del Mistro(Center for Regenerative Therapies Dresden), Dagmar Kulms(National Center for Tumor Diseases), Stefan Beissert(University Hospital Carl Gustav Carus), Meike Hutt(University of Stuttgart), Martin Siegemund(University of Stuttgart), Philippe Lucarelli(University of Luxembourg), Thomas Sauter(University of Luxembourg), Anna Zinoveva(Center for Regenerative Therapies Dresden), Roland E. Kontermann(University of Stuttgart), Sébastien De Landtsheer(University of Luxembourg), Ines Müller(Mount Sinai Hospital)
Cited by 7
Related Papers
Lack of beta-arrestin signaling in the absence of active G proteins
|Nature Communications|2018|382
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332
The gut microbial metabolite formate exacerbates colorectal cancer progression
|Nature Metabolism|2022|301